IQVIA Holdings | IQV - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Accenture USD 3.18B 681.75M 2026-03
Agilent USD 399M 46M 2026-03
Bruker USD 10.2M 66.1M 2026-03
Cardinal Health USD 861M 98M 2026-03
Celltrion KRW 13.72B 287.31B 2025-12
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cigna USD 2.76B 204M 2026-03
Cognizant Technology Solutions USD 843M 10M 2026-03
Computer Programs Systems USD -119.41M 121.35M 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
CVS Health USD 4.68B 2.57B 2026-03
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 8.14B 420M 2026-03
Elevance Health USD -5.81B 6.39B 2026-03
Humana USD 1.75B 2.56B 2026-03
IBM USD 4.25B 1.7B 2025-12
Illumina USD 239M 17M 2026-03
Infosys INR 84.09B 83.02B 2025-12
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 410.1M 28.1M 2026-03
Malin Corporation EUR -1.1M 400K 2024-12
McKesson USD 1.84B 181M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pharma Mar EUR 622K 42.99M 2026-03
Publicis EUR 1.39B 189M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Revvity USD 82.77M 63.06M 2026-03
Sartorius EUR 160.7M 9.5M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Tilray USD -20.01M 9.34M 2025-09
UnitedHealth USD 9.04B 5.78B 2026-03
Veeva Systems USD 273.11M 27.24M 2026-03
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 148M 122.52M 2026-03
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03